The hottest event of the year is back and bigger than ever!
Set your sights on the next wave of eyecare advancement November 6-7 at Eyes On 2027, showcasing 12 dynamic clinical sessions covering the biggest breakthroughs across across retina, ocular surface, glaucoma, myopia, and beyond! Discover new treatments, diagnostic approaches, and clinical data from top industry leaders while earning up to 8 FREE COPE-approved CE hours live. Save your spot today!
New Content
Beyond Compounding: An FDA-Approved Bevacizumab Option for Wet AMD
Extended Parameters in Practice: My Workflow for Expanding Contact Lens Access
Learn how expanded cylinder/axis parameters in daily disposable toric lenses let practitioners more effectively correct astigmatic patients' full prescriptions.
Realities of Inherited Retinal Disease: Patient Perspectives and Pearls
Join Drs. Rishi P. Singh and Aaron Nagiel as they discuss the unique challenges that patients with inherited retinal diseases (IRDs) face in getting treatment.
Innovations in Dry Eye Symptom Relief: Long-Lasting Relief With Systane PRO
The ONLY triple action preservative-free formula that provides up to 12 hours of Dry Eye relief1*
Topics
The B Vitamin Conversation You Should Be Having with AMD Patients
Taking a Closer Look at Cosmetic Laser Retinopathy
The High-Performance Contact Lens Workflow: Save 10+ Minutes Per Patient
Eyetamins by Optase target eyes prone to dryness with omega-7
Plant-based, softgel supplements are formulated to address long-term eye health with moisture balance support; upcoming AAO symposium dives deeper into the benefits.
MyEyeDr to purchase EyeCare Partners' optometry division
Acquisition includes 300+ offices from top regional brands offering personalized eyecare and doctor-led service model; Q4 closing is expected.
Sagent launches ready-to-use indocyanine green injection to US market
Optical imaging agent is reported to be the first FDA-approved ICG injection of its kind—with no reconstitution needed prior to use.
Beacon Therapeutics releases positive topline phase 2 data on laru-zova for XLRP
Beyond Compounding: An FDA-Approved Bevacizumab Option for Wet AMD
Join Rishi P. Singh, MD, FASRS and Bob Jahr of Outlook Therapeutics as they discuss the FDA approval of bevacizumab.
Is Demodex the Missing Link in MGD?
Join Drs. Mile Brujic and Laura M. Periman as they provide insights into the link between Demodex blepharitis and meibomian gland dysfunction (MGD).
$1 or Mystery Gift - Myopia Myths Edition
Find out what your fellow optometrists know about myopia management by playing the game, $1 or Mystery Gift!
Clinical Specialties
Extended Parameters in Practice: My Workflow for Expanding Contact Lens Access
Realities of Inherited Retinal Disease: Patient Perspectives and Pearls
Innovations in Dry Eye Symptom Relief: Long-Lasting Relief With Systane PRO
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.
Utilizing AI to Increase Eyecare Practice Efficiency
Discover artificial intelligence (AI)-based platforms that eyecare providers can use to solve workflow problems to improve practice efficiency.
How AI Can Streamline Contact Lens Workflows
Learn how eyecare practitioners can integrate artificial intelligence (AI) into their contact lens workflows to improve practice efficiency and profitability.
Careers
The Ultimate Guide to Starting a Dry Eye Practice with Check List
Closing the Contact Lens Gap: Engaging Every Eligible Patient
Innovations in Dry Eye Symptom Relief: Long-Lasting Relief With Systane PRO
The ONLY triple action preservative-free formula that provides up to 12 hours of Dry Eye relief1*
